Zur Kurzanzeige

dc.identifier.uri http://dx.doi.org/10.15488/3345
dc.identifier.uri http://www.repo.uni-hannover.de/handle/123456789/3375
dc.contributor.author Ludwig, K.
dc.contributor.author Schulenburg, Johann-Matthias Graf von der
dc.contributor.author Greiner, W.
dc.date.accessioned 2018-05-23T06:37:52Z
dc.date.available 2018-05-23T06:37:52Z
dc.date.issued 2018
dc.identifier.citation Ludwig, K.; Graf von der Schulenburg, J.-M.; Greiner, W.: German Value Set for the EQ-5D-5L. In: PharmacoEconomics 2018 (2018), 1-12. DOI: https://doi.org/10.1007/s40273-018-0615-8
dc.description.abstract Objectives: The objective of this study was to develop a value set for EQ-5D-5L based on the societal preferences of the German population. As the first country to do so, the study design used the improved EQ-5D-5L valuation protocol 2.0 developed by the EuroQol Group, including a feedback module as internal validation and a quality control process that was missing in the first wave of EQ-5D-5L valuation studies. Methods: A representative sample of the general German population (n = 1158) was interviewed using a composite time trade-off and a discrete choice experiment under close quality control. Econometric modeling was used to estimate values for all 3125 possible health states described by EQ-5D-5L. The value set was based on a hybrid model including all available information from the composite time trade-off and discrete choice experiment valuations without any exclusions due to data issues. Results: The final German value set was constructed from a combination of a conditional logit model for the discrete choice experiment data and a censored at −1 Tobit model for the composite time trade-off data, correcting for heteroskedasticity. The value set had logically consistent parameter estimates (p < 0.001 for all coefficients). The predicted EQ-5D-5L index values ranged from −0.661 to 1. Conclusions: This study provided values for the health states of the German version of EQ-5D-5L representing the preferences of the German population. The study successfully employed for the first time worldwide the improved protocol 2.0. The value set enables the use of the EQ-5D-5L instrument in economic evaluations and in clinical studies. © 2018 The Author(s) eng
dc.language.iso eng
dc.publisher New York, NY : Springer International Publishing
dc.relation.ispartofseries PharmacoEconomics 2018 (2018)
dc.rights CC BY-NC 4.0 Unported
dc.rights.uri https://creativecommons.org/licenses/by-nc/4.0/
dc.subject EQ-5D-5L eng
dc.subject German population eng
dc.subject EuroQol Group eng
dc.subject health eng
dc.subject.ddc 610 | Medizin, Gesundheit ger
dc.title German Value Set for the EQ-5D-5L
dc.type Article
dc.type Text
dc.relation.issn 1170-7690
dc.relation.doi https://doi.org/10.1007/s40273-018-0615-8
dc.bibliographicCitation.volume 2018
dc.bibliographicCitation.firstPage 1
dc.bibliographicCitation.lastPage 12
dc.description.version publishedVersion
tib.accessRights frei zug�nglich


Die Publikation erscheint in Sammlung(en):

Zur Kurzanzeige

 

Suche im Repositorium


Durchblättern

Mein Nutzer/innenkonto

Nutzungsstatistiken